FR 
EN 
Clinical Trial Insights
Welcome to Cytel’s Insights hub—your go-to destination for the latest news, event updates, and expert insights on advanced analytical methods and data science. Come on in!
Revolutionizing Breast Cancer Care
Discover our latest groundbreaking breast cancer research: “Omitting Axillary Dissection in Breast Cancer,” published in NEJM. This collaborative effort with the SENOMAC Trialists’ Group pioneers a new treatment approach that reduces side effects while maintaining efficacy. With its significant impact on treatment protocols and patient outcomes, the new approach has the potential to transform the future of breast cancer care.
Lire la suitePerspectives
Our experts share cutting-edge insights, industry trends, and in-depth analyses spanning the full spectrum of drug lifecycle management, from initial development through to successful commercialization.
News and Events
Stay up to date with the latest news and events here at Cytel and beyond. We will inform you about the upcoming industry events, our participation and contribution, keeping you connected and in the know.
Resource Library
The Cytel Library is always open—explore our extensive collection of articles, white papers, case studies, and more to discover how we are shaping the future of drug development.
Publications
Stay up to date with our latest peer-reviewed publications on our Cytel pubmed page.
Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer. Struebing A, McKibbon C, Ruan H, Mackay E, Dennis N, Velummailum R, He P, Tanaka Y, Xiong Y, Springford A, Rosenlund M., J Comp Eff Res. 2024
Clinical outcomes for previously treated patients with advanced biliary tract cancer: a meta-analysis. Amonkar MM, Abderhalden LA, Fox GE, Frederickson AM, Grira T, Gozman A, Malhotra U, Malbecq W, Akers KG., Future Oncol. 2024
Justifying the source of external comparators in single-arm oncology health technology submissions: a review of NICE and PBAC assessments. Appiah K, Rizzo M, Sarri G, Hernandez L., J Comp Eff Res. 2024
Epidemiology and Real-World Treatment of Incident Diffuse Large B-cell Lymphoma (DLBCL): A German Claims Data Analysis. Pacis S, Bolzani A, Heuck A, Gossens K, Kruse M, Fritz B, Maywald U, Wilke T, Kunz C., Oncol Ther. 2024
Cytel Design Institute
Visit the Cytel Design Institute to uncover the workings of our advanced clinical trial design. We share 35+ years of pioneering expertise, from innovative study design to powerful real-world evidence applications.
Learn more about the Cytel Design InstituteDemandez une séance gratuite de 30 minutes pour votre stratégie
Réservez une séance de stratégie gratuite et sans obligation avec un expert de Cytel pour obtenir des conseils afin d’améliorer les chances de réussite de votre médicament et définir un parcours plus clair vers le marché.
